Insider Selling: Seer (NASDAQ:SEER) Director Sells $23,238.80 in Stock

Seer, Inc. (NASDAQ:SEER) Director Dipchand Nishar sold 10,660 shares of Seer stock in a transaction on Wednesday, July 8th. The shares were sold at an average price of $2.18, for a total value of $23,238.80. Following the transaction, the director owned 59,044 shares of the company’s stock, valued at $128,715.92. The trade was a 15.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Seer Stock Performance

NASDAQ SEER opened at $2.17 on Monday. Seer, Inc. has a 12 month low of $1.55 and a 12 month high of $2.41. The stock’s fifty day moving average price is $1.81 and its 200-day moving average price is $1.84. The stock has a market cap of $119.31 million, a P/E ratio of -1.75 and a beta of 1.59.

Seer (NASDAQ:SEER) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). The firm had revenue of $2.79 million during the quarter, compared to analyst estimates of $3.60 million. Seer had a negative return on equity of 26.58% and a negative net margin of 464.78%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Canaccord Genuity Group assumed coverage on shares of Seer in a report on Monday, May 4th. They set a “buy” rating and a $4.00 price target on the stock. TD Cowen raised Seer to a “strong-buy” rating in a research report on Monday, April 13th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Seer in a research note on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $4.00.

Institutional Trading of Seer

A number of institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its stake in shares of Seer by 51.6% in the first quarter. Goldman Sachs Group Inc. now owns 170,897 shares of the company’s stock worth $289,000 after acquiring an additional 58,173 shares during the period. Jane Street Group LLC lifted its holdings in Seer by 33.3% in the first quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock valued at $430,000 after acquiring an additional 63,432 shares during the period. Geode Capital Management LLC increased its position in shares of Seer by 16.5% during the 2nd quarter. Geode Capital Management LLC now owns 509,727 shares of the company’s stock valued at $1,091,000 after purchasing an additional 72,265 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of Seer during the 2nd quarter valued at about $172,000. Finally, Occudo Quantitative Strategies LP bought a new position in shares of Seer in the 2nd quarter worth approximately $25,000. Hedge funds and other institutional investors own 75.20% of the company’s stock.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.